 Connection
Samantha Stonbraker to Pre-Exposure Prophylaxis
This is a "connection" page, showing publications Samantha Stonbraker has written about Pre-Exposure Prophylaxis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.494 |
|
|
|
-
Tagliaferri Rael C, Das D, Giguere R, Porter J, Bryndza Tfaily E, Tuswa Haynes C, Ho T, McKenna S, Lopez-Ríos J, Lentz C, Dolezal C, Stonbraker S, Hendrix C, D'Aquila RT, Hope TJ. Provider Preferences on Existing and Potential Future Biomedical HIV Prevention Products: A Qualitative Study in the United States, Thailand, and South Africa. AIDS Res Hum Retroviruses. 2026 Oct-Nov; 42(10-11):307-317.
Score: 0.189
-
Rael CT, Das D, Porter J, Lopez-Ríos J, Abascal E, Dolezal C, Vaughn MP, Giffenig P, Lopez JM, Stonbraker S, Sun C, Velasco RA, Bitterfeld L, Bockting WO, Bauermeister J. Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women in the United States: Results of a Qualitative Study. J Assoc Nurses AIDS Care. 2024 Sep-Oct 01; 35(5):437-449.
Score: 0.164
-
Bracho-Sanchez E, Stonbraker S, Halpern M, Wood S, Lowenthal E. HIV pre-exposure prophylaxis: assessment of acceptability among members of HIV serodiscordant/serostatus unknown couples. Int J STD AIDS. 2022 06; 33(7):687-693.
Score: 0.140
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|